These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 29398302)

  • 1. Organs-on-a-chip: Current applications and consideration points for in vitro ADME-Tox studies.
    Ishida S
    Drug Metab Pharmacokinet; 2018 Feb; 33(1):49-54. PubMed ID: 29398302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organ/body-on-a-chip based on microfluidic technology for drug discovery.
    Kimura H; Sakai Y; Fujii T
    Drug Metab Pharmacokinet; 2018 Feb; 33(1):43-48. PubMed ID: 29175062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-based absorption, distribution, metabolism, excretion (ADME) and its interplay with alternative toxicity methods.
    Tsaioun K; Blaauboer BJ; Hartung T
    ALTEX; 2016; 33(4):343-358. PubMed ID: 27806179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of metabolism-dependent drug efficacy and toxicity on a multilayer organs-on-a-chip.
    Li Z; Guo Y; Yu Y; Xu C; Xu H; Qin J
    Integr Biol (Camb); 2016 Oct; 8(10):1022-1029. PubMed ID: 27605158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An on-chip small intestine-liver model for pharmacokinetic studies.
    Kimura H; Ikeda T; Nakayama H; Sakai Y; Fujii T
    J Lab Autom; 2015 Jun; 20(3):265-73. PubMed ID: 25385717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Development in Organ-On-A-Chip Technology.
    Joseph X; Akhil V; Arathi A; Mohanan PV
    J Pharm Sci; 2022 Jan; 111(1):18-31. PubMed ID: 34324944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADME-Tox in drug discovery: integration of experimental and computational technologies.
    Yu H; Adedoyin A
    Drug Discov Today; 2003 Sep; 8(18):852-61. PubMed ID: 12963322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Judging the value of 'liver-on-a-chip' devices for prediction of toxicity.
    Starokozhko V; Groothuis GM
    Expert Opin Drug Metab Toxicol; 2017 Feb; 13(2):125-128. PubMed ID: 27724053
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic insights from microfluidic intestine-on-a-chip models.
    Lee SH; Choi N; Sung JH
    Expert Opin Drug Metab Toxicol; 2019 Dec; 15(12):1005-1019. PubMed ID: 31794278
    [No Abstract]   [Full Text] [Related]  

  • 10. Systems-ADME/Tox: resources and network approaches.
    Ekins S
    J Pharmacol Toxicol Methods; 2006; 53(1):38-66. PubMed ID: 16054403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards human
    Stevens LJ; Donkers JM; Dubbeld J; Vaes WHJ; Knibbe CAJ; Alwayn IPJ; van de Steeg E
    Drug Metab Rev; 2020 Aug; 52(3):438-454. PubMed ID: 32551945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microphysiological systems for ADME-related applications: current status and recommendations for system development and characterization.
    Fowler S; Chen WLK; Duignan DB; Gupta A; Hariparsad N; Kenny JR; Lai WG; Liras J; Phillips JA; Gan J
    Lab Chip; 2020 Feb; 20(3):446-467. PubMed ID: 31932816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin and kidney equivalents.
    Maschmeyer I; Lorenz AK; Schimek K; Hasenberg T; Ramme AP; Hübner J; Lindner M; Drewell C; Bauer S; Thomas A; Sambo NS; Sonntag F; Lauster R; Marx U
    Lab Chip; 2015 Jun; 15(12):2688-99. PubMed ID: 25996126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic stability for drug discovery and development: pharmacokinetic and biochemical challenges.
    Masimirembwa CM; Bredberg U; Andersson TB
    Clin Pharmacokinet; 2003; 42(6):515-28. PubMed ID: 12793837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive Multitask Deep Neural Network Models for ADME-Tox Properties: Learning from Large Data Sets.
    Wenzel J; Matter H; Schmidt F
    J Chem Inf Model; 2019 Mar; 59(3):1253-1268. PubMed ID: 30615828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From organ-on-chip to body-on-chip: The next generation of microfluidics platforms for in vitro drug efficacy and toxicity testing.
    Lacombe J; Soldevila M; Zenhausern F
    Prog Mol Biol Transl Sci; 2022; 187(1):41-91. PubMed ID: 35094781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Laminated Microfluidic Device for Comprehensive Preclinical Testing in the Drug ADME Process.
    An F; Qu Y; Luo Y; Fang N; Liu Y; Gao Z; Zhao W; Lin B
    Sci Rep; 2016 Apr; 6():25022. PubMed ID: 27122192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pharmaceutical industry perspective on microphysiological kidney systems for evaluation of safety for new therapies.
    Phillips JA; Grandhi TSP; Davis M; Gautier JC; Hariparsad N; Keller D; Sura R; Van Vleet TR
    Lab Chip; 2020 Feb; 20(3):468-476. PubMed ID: 31989145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of absorption, metabolism and toxicity of ginsenosides compound K based on human organ chips.
    Liu D; Jiao S; Wei J; Zhang X; Pei Y; Pei Z; Li J; Du Y
    Int J Pharm; 2020 Sep; 587():119669. PubMed ID: 32702454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolizing enzyme toxicology assay chip (MetaChip) for high-throughput microscale toxicity analyses.
    Lee MY; Park CB; Dordick JS; Clark DS
    Proc Natl Acad Sci U S A; 2005 Jan; 102(4):983-7. PubMed ID: 15657119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.